Document is current
Any future updates will be listed below
-
Authors
Gao, Huanhuan
Zhu, Yi https://orcid.org/0000-0003-0429-0802
Wang, Dongxue
Nie, Zongxiang
Wang, He
Wang, Guibin
Liang, Shuang
Xie, Yuting
Sun, Yingying
Jiang, Wenhao https://orcid.org/0009-0000-9381-9848
Dong, Zhen https://orcid.org/0000-0002-3480-3421
Qian, Liqin
Wang, Xufei
Liang, Mengdi
Chen, Min
Fang, Houqi
Zeng, Qiufang
Tian, Jiao
Sun, Zeyu https://orcid.org/0000-0003-0218-2277
Xue, Juan
Li, Shan https://orcid.org/0000-0001-8646-3193
Chen, Chen
Liu, Xiang
Lyu, Xiaolei
Guo, Zhenchang
Qi, Yingzi
Wu, Ruoyu
Du, Xiaoxian
Tong, Tingde
Kong, Fengchun
Han, Liming
Wang, Minghui
Zhao, Yang https://orcid.org/0000-0003-1444-5927
Dai, Xinhua
He, Fuchu https://orcid.org/0000-0002-1094-4019
Guo, Tiannan https://orcid.org/0000-0003-3869-7651
- License Information
-
More Information
Article History
Received: 31 May 2024
Accepted: 22 November 2024
First Online: 21 January 2025
Competing interests
: T.G. and Y. Zhu are shareholders of Westlake Omics Biotechnology Co., Ltd. Three patents related to iDIA-QC technologies have been filed. Two have been granted, with the numbers CN 114858958 B and CN 116106464 B, while the third is currently pending, with the application number CN 202210783026.2. Y.L., Z.N. and Y.L. are employees of Westlake Omics Inc. H.F. and M.C. are employees of Shanghai Luming Biological Technology Inc. Q.F. and J.T. are employees of Shanghai Applied Protein Technology co. ltd. C.C., X.L., X.L. and F.K. were employees of SCIEX China during this project. Z.G., Y. Q. and T.T. are employees of Thermo Fisher Scientific China while R.W., X.D., L.M. and M.W. are employees of Bruker Daltonics China. The remaining authors declare no competing interests.
